Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Incyte INCY G&A

G&A at other companies

Celldex TherapeuticsCLDX

$11.45M+5.8%

Protagonist TherapeuticsPTGX

$13.28M+13.1%

Syndax PharmaceuticalsSNDX

$37.59M-8.4%

Aclaris TherapeuticsACRS

$6.74M+9.8%

Cogent Biosciences, Inc.COGT

$28.24M+137%

Tyra Biosciences, Inc.TYRA

$8.53M+23.8%

Segments

By segment

See full

Reportable Segment$65.98M-11.7%

Other financials

Income statement

See full

Revenue$1.7B+37.7%

Gross profit$1.6B+38.0%

Operating income$697.9M+31.6%

Net income$585.6M+44.6%

EPS (diluted)$2.81+37.7%

Balance sheet

See full

Cash & equivalents$4.0B+104%

Total debt$38.3M-9.8%

Total equity$6.3B+52.1%

Total assets$7.9B+35.2%

Cash flow

See full

Operating cash flow$507.7M+1,035%

CapEx$1.6M-43.5%

Free cash flow$509.3M+1,069%

Valuation

See full

Market cap$25.76B+70.1%

Enterprise value$21.82B+64.9%

P/E16×-1.4×

P/S4.4×+1.1×

Profitability

See full

Gross margin92.6%-0.3pp

Operating margin30.6%+4.8pp

Net margin27.7%+8.7pp

FCF margin34%+12.3pp

Returns & leverage

See full

Return on equity30.7%+6.4pp

Debt / equity0×0.0×

Current ratio4.6×+1.7×

Questions, answered.

What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.